Search Medical Condition
Please enter condition
Please choose location

Allergy (Pediatric) Clinical Trials

A listing of Allergy (Pediatric) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (20) clinical trials

The Basophil Activation Test as a Diagnostic Tool in Pediatric Food Allergy

Background: The need for an oral food challenge (OFC) surrogate is growing in line with the continuous increase in the prevalence and severity of paediatric food allergy. The basophil activation test (BAT) has recently been reported as a promising tool for predicting the outcome of OFC in children. Objective: We ...

Phase N/A

A Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis

The purpose of this study is to evaluate the safety, tolerability and the pharmacokinetics (PK) of topical INCB018424 cream applied to pediatric subjects (age 12 to 17 years) with atopic dermatitis (AD).

Phase

Oral Challenge in the Pediatric ED

Our primary objective is to demonstrate the feasibility of utilizing a novel penicillin allergy questionnaire in the PED to identify a low-risk group of patients who will complete an oral challenge in the PED to test for an IgE-mediated allergic reaction. This project will begin as a single site feasibility ...

Phase

The Development of Novel Clinical Tests to Diagnose and Monitor Asthma in Preschool Children

In Canada, the most common chronic disease of childhood is asthma. Childhood asthma places a significant burden on the health care system (refn). No objective preschool asthma diagnostic tools exist, and the current gold-standard, the Asthma Predictive Index, does not provide information about lung function and symptom management. In this ...

Phase

Bathing Additives in Pediatric Atopic Dermatitis

The current clinical guidelines for management of atopic dermatitis now recommend bleach baths. This requires simply the addition of regular household bleach to twice-weekly baths. At the Mayo Clinic, dilute acetic acid (vinegar) has been recommended for decades in wet wraps to treat patients hospitalized for their atopic dermatitis. However, ...

Phase N/A

Pediatric Arm of DZL All Age Asthma Cohort

About 25-30% of children have at least one episode of wheeze before their 3rd birthday, but considerable clinical heterogeneity exists. Many of these children become symptom-free between 3 and 8 years of age, but some go on to persistent asthma in later childhood and adulthood. Despite its high prevalence, still ...

Phase N/A

Establishing the Collaborative Care Model of Traditional Chinese Medicine and Western Medicine-Pediatric Atopic Dermatitis

In Taiwan, there are many patients suffer from pediatric atopic dermatitis. Because of the clinical characteristic of repetitive and scratchy, which will affect the patients' quality of life and lead to the medical heavy budget. TCM may play an important role in this disease and help patient to improved their ...

Phase N/A

Behavioral Self-Help Intervention for Pediatric Atopic Dermatitis and Eczema Patients

Background Psychological interventions for atopic dermatitis (AD) in children are not well-studied, despite the potential benefits, which may include: decreased need for medications and improved long-term control of both dermatologic symptoms as well as other secondary symptoms that may impact quality of life, such as anxiety, insomnia, and psychosocial distress. ...

Phase N/A

Asthma and Atopic Dermatitis Validation of PROMIS Pediatric Instruments

This study involves a series of research and development projects targeted at two of the most common chronic diseases affecting children: asthma and atopic dermatitis (AD, or eczema). The Investigators propose to directly validate patient-reported outcomes (PRO) measures in a large cohort of itch-specific pediatric skin conditions, with a primary ...

Phase N/A

Open-Label Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis

The purpose of this multicenter, open-label study is to evaluate the safety, tolerability, and pharmacokinetics of RVT-501 0.5% topical ointment administered twice daily (BID) for 4 weeks in pediatric patients age 2-11 years of age with extensive atopic dermatitis. The efficacy of RVT-501 will also be evaluated as a secondary ...

Phase